In the BioHarmony Drug Report Database
Atazanavir
Reyataz (atazanavir) is a small molecule pharmaceutical. Atazanavir was first approved as Reyataz on 2003-06-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
Trade Name
|
Reyataz |
|---|---|
Common Name
|
atazanavir |
ChEMBL ID
|
CHEMBL1163 |
Indication
|
acquired immunodeficiency syndrome, hiv infections |
Drug Class
|
Antivirals: HIV protease inhibitors (saquinavir type) |
Image (chem structure or protein)